Form Health's GLP-1 Option: What the Program Includes

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic factors behind every metabolic decision. Browse all Peptides & GLP-1 education.

What "GLP-1" actually covers

Anyone researching Form Health's GLP-1 option benefits from a clear definition first. GLP-1 refers to a class of medications — GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide — alongside the GIP/GLP-1 dual agonist tirzepatide, which adds a second incretin pathway. Form Health is an obesity-medicine telehealth program, one of many in this category as of April 2026, and this overview explains where its GLP-1 offering fits.

Independence note: PlexusDx has no partnership, affiliate arrangement, or paid placement with Form Health. This overview is unsponsored.

How the GLP-1 class works in the body

These compounds act on appetite regulation, satiety signaling, and gastric emptying. GLP-1 receptor agonists engage a single receptor; the dual agonist tirzepatide engages two. The effect a person experiences traces to the compound and dose, not to the telehealth brand that arranges the prescription — a distinction worth holding onto when comparing programs.

How Form Health delivers the offering

The clinical workflow

The program follows a familiar sequence: an intake covering weight, medical history, and medications; review by a licensed clinician; a prescription if eligibility is met; fulfillment through a retail or 503A compounding pharmacy; and follow-up for titration and side-effect management. Form Health's obesity-medicine emphasis centers this on clinician-led care.

Dispensing pathways

A GLP-1 prescription can route to a retail pharmacy for an FDA-approved brand product or to a licensed compounding pharmacy for a compounded semaglutide or tirzepatide. Compounded medications are not FDA-approved finished drug products. Current specifics are on Form Health's official website.

What the GLP-1 evidence base shows

The class carries substantial trial support tied to the molecules: STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024). Endpoints and populations differ across trials, and individual outcomes vary.

What a GLP-1 offering typically costs

Form Health posts current pricing on its own site, and it changes. Across GLP-1 telehealth programs as of April 2026, monthly totals commonly range from roughly $200 to $700 or more depending on compound, subscription tier, and dispensing pathway. Verify the live figure before committing, since the compound you are prescribed and the pathway it routes through can each move the total meaningfully.

The genetic context upstream of every GLP-1 prescription

A GLP-1 offering does not examine the genetics that shape how your body meets these compounds. Variants in GLP1R (the receptor the class targets), FTO, MC4R, and TCF7L2 describe your metabolic baseline — pathway-level context, not a prediction of drug response. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, and its Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights so you and your provider begin with more than a prescription.

A helpful frame when evaluating any GLP-1 offering is to separate the class from the brand delivering it. The compound and dose set the biology; the telehealth program sets the access, oversight, and price around it. Comparing programs on those service factors is more informative than comparing them on the medication alone.

No affiliation: PlexusDx has no commercial relationship with Form Health or any brand named in this overview.

Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.

Editorial disclaimer: This overview is educational and independent. PlexusDx sells semaglutide and tirzepatide through its own Weight Management Protocols and is not affiliated with Form Health. The Precision Peptide Genetic Test reflects how your genes influence peptide-related pathways — it does not predict response to any specific medication. Consult a licensed provider before starting a protocol.

Frequently Asked Questions

Which GLP-1 medications does Form Health's model cover?

The GLP-1 class includes receptor agonists such as semaglutide, plus the GIP/GLP-1 dual agonist tirzepatide. Which specific compounds Form Health offers, and in what forms, is posted on its own site and can change. Confirm the current medication menu directly before enrolling.

Does the program use brand-name or compounded GLP-1s?

Depending on eligibility and availability, prescriptions route to a retail pharmacy for FDA-approved brand products or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Compounded medications are not FDA-approved finished drug products. Verify which pathway applies with Form Health directly.

How much does the GLP-1 option cost per month?

Form Health publishes current pricing on its site, and it changes. GLP-1 telehealth totals as of April 2026 commonly range from roughly $200 to $700 or more per month depending on compound, tier, and dispensing pathway. Verify the live figure before committing.

Should genetics factor into starting a GLP-1?

Genetics will not predict how you respond to a GLP-1 medication. The Precision Peptide Genetic Test instead maps pathway-level variants in GLP1R, FTO, and MC4R that describe your metabolic baseline — context to bring to a provider alongside clinical evaluation, not a substitute for it.

Continue learning in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.